FDA chief Gottlieb backs away from plan to publish CRLs
June 28, 2018 People inside and outside the FDA have long discussed the publication of the CRLs the Agency sends to companies to notify them it is rejecting their applications for approval. Such transparency would enable everyone to know why the FDA rejected an application. Today, researchers, investors and other interested parties rely on the … Read more